MRS. GRACE A MAKHLOUF M.D. NPI 1124073655

NPI Details

MRS. Grace A Makhlouf, M.D. is a specialist in Sugar Land, TX with 34 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. MRS. Grace A Makhlouf, M.D. NPI is 1124073655. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1429 HIGHWAY 6 SOUTH
STE 103
SUGAR LAND, TX
ZIP 77478-135
Phone: (713) 273-5881
Fax: (713) 273-5820

The NPI 1124073655 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Liver function blood test panel (HCPCS:80076)
• Blood creatinine level (HCPCS:82565)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Ferritin (blood protein) level (HCPCS:82728)
• Folic acid level, serum (HCPCS:82746)
• Iron level (HCPCS:83540)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)

The enumeration date for this NPI number is 5/23/2006 and was last updated on 3/1/2012.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.